Find generic entry opportunities
Manage your formulary budget
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions|
|Abstract:||The present invention is directed to certain 2'-fluoro, 2-substituted purine nucleosides which are toxic to cancerous cell lines.|
|Inventor(s):||Montgomery; John A. (Birmingham, AL), Secrist, III; John A. (Birmingham, AL)|
|Assignee:||Southern Research Institute (Birmingham, AL)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Dosage form;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0473708||► subscribe||06C0038||France||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.